New pill KDS2010 aims to shed pounds in obesity trial
NCT ID NCT07009171
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental drug called KDS2010 for weight loss in 75 overweight or obese adults. Participants take the drug or a placebo daily for 12 weeks. The main goal is to see how much weight they lose and if the drug is safe. It is a Phase 2a trial, meaning it is still early and mainly checks if the drug works and what dose might be best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KDS2010
What this could lead to
If successful, KDS2010 could offer a new oral medication for weight loss in people who are overweight or obese.
What could go wrong
This is an early Phase 2a trial with only 75 participants, so results may not confirm effectiveness or safety. Weight loss drugs often have side effects and may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Kangbuk Samsung Medical Center
RECRUITINGSeoul, Seoul, 03181, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
The Catholic University of Korea, St. Vincent's Hospital
RECRUITINGSuwon, Gyeonggi-do, 16247, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, Seoul, 03722, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact